Clinical pharmacogenetics in pediatric patients.

Abstract

Pediatric pharmacogenetic studies have the potential to improve the quality of medical care for children. The pediatric population presents a unique pharmacogenetic challenge as children have the additional complexity of ontological phenotypes that impact their drug response. Prescribing medications in children has historically been largely empirical, but utilization of pharmacogenetic information will allow pediatricians to gain key information regarding which patients are best suited for a particular therapeutic agent and which patients may be at risk for serious potentially life-threatening complications from standard treatment regimens. Although large, prospective, multisite investigators are still needed, we illustrate selective clinical examples of the pharmacogenetics for treatment of transplantation, asthma, leukemia and attention-deficit hyperactivity disorder in pediatric patients.

Statistics

01002002008200920102011201220132014201520162017
Citations per Year

155 Citations

Semantic Scholar estimates that this publication has 155 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Husain2007ClinicalPI, title={Clinical pharmacogenetics in pediatric patients.}, author={Anwar Husain and Jennifer A Loehle and David W Hein}, journal={Pharmacogenomics}, year={2007}, volume={8 10}, pages={1403-11} }